Diabetes News

Medindia's Press Release’ section provides the latest press release on Diabetes from across the world for the global audience. This page links to 1424 Diabetes press releases.

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

PR Newswire SILVER SPRING, Md., Dec. 23, 2024 SILVER SPRING, Md., Dec. 23, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a ...


A chronic issue - disease rates climbing among young Canadians

Canada NewsWire TORONTO, Dec. 11, 2024 New report finds drug claims for chronic diseases like diabetes and high blood pressure on the rise TORONTO, Dec. 11, 2024 /CNW/ - Chronic diseases don't discriminate when it comes to age. A new ...

9amHealth Becomes First Virtual Cardiometabolic Care Provider to Achieve CDC's Highest Recognition for Diabetes Prevention Program

PR Newswire SAN DIEGO, Dec. 11, 2024 Cohort Outperforms National Averages, Setting a New Standard for Diabetes Prevention for Employers and Health Plans SAN DIEGO, Dec. 11, 2024 /PRNewswire/ -- 9amHealth, the leading virtual ...

UMass Memorial Health Integrates AEYE Health's AEYE-DS Autonomous AI Screening for Diabetic Eye Care into EMR System

PR Newswire NEW YORK, Dec. 10, 2024 In Memory of Dr. James Ledwith NEW YORK, Dec. 10, 2024 /PRNewswire/ -- AEYE Health , the leader in artificial intelligence-based diagnostics for retinal imaging, and UMass Memorial Health  (UMMH), the ...

The American Diabetes Association Releases Standards of Care in Diabetes--2025

PR Newswire ARLINGTON, Va., Dec. 9, 2024 New recommendations on nutrition, weight-loss medications and technology ARLINGTON, Va., Dec. 9, 2024 /PRNewswire/ -- Today, the American Diabetes Association® released the Standards of Care in ...

Cinesteam® Is Addressing Malodors From Diabetic Foot Ulcers

PR Newswire FORT LAUDERDALE, Fla., Dec. 6, 2024 In a Month Focused on Diabetes Awareness, the Health Brand's Secondary Dressing Is Helping to Provide Comprehensive Quality of Life for Patients With DFUs FORT LAUDERDALE, Fla., Dec. 6, ...

CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial

PR Newswire MELBOURNE, Australia, Dec. 4, 2024 MELBOURNE, Australia, Dec. 4, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, ...

Hyundai Donates to UCI Health to Support Diabetes Services

PR Newswire FOUNTAIN VALLEY, Calif., Dec. 3, 2024 FOUNTAIN VALLEY, Calif., Dec. 3, 2024 /PRNewswire/ -- Hyundai Motor America announced a $50,000 donation to UCI Health to bolster its diabetes support services at the UCI Health Family Health ...

Alleviating the Burden in Treating Type 1 Diabetes and Chronic Kidney Disease

PR Newswire MISSION, Kan., Nov. 25, 2024 MISSION, Kan., Nov. 25, 2024 /PRNewswire/ -- (Family Features) While diabetes gets a lot of attention, people with Type 1 Diabetes (T1D) are frequently overlooked when drug companies develop new ...

Understanding Diabetes: HME Square Inc. is featured on Viewpoint with Dennis Quaid

PR Newswire MIAMI, Nov. 13, 2024 Millions of people across the United States navigate the challenges of diabetes, a complex condition that requires ongoing management. Viewpoint with Dennis Quaid sheds light on this journey, featuring HME ...

Diabetes News »

Dysregulated Cellular Activity Drives Type 2 Diabetes

Dysregulated Cellular Activity Drives Type 2 Diabetes

Researchers are studying overactive cells linked to type 2 diabetes and cardiovascular disorders, aiming to develop targeted therapies for better treatment options.

Speeding Up Detection: Quick Blood Processing to Identify Gestational Diabetes Early

Speeding Up Detection: Quick Blood Processing to Identify Gestational Diabetes Early

Diabetes during pregnancy? Don't let undiagnosed gestational diabetes put your pregnancy at risk. Faster blood processing could save thousands of women from complications.

Cipla Gets Green Light from CDSCO for Inhaled Insulin

Cipla Gets Green Light from CDSCO for Inhaled Insulin

Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative drug delivery.

HPH-15: The Dual-Action Wonder for Diabetes and Obesity

HPH-15: The Dual-Action Wonder for Diabetes and Obesity

HPH-15, a novel compound, shows promise in treating Type 2 diabetes by reducing blood glucose levels and combating fat accumulation.

Genes Linked to Early Diabetes in South Asians

Genes Linked to Early Diabetes in South Asians

Discover key genes linked to early diabetes in South Asians, highlighting unique genetic factors contributing to higher susceptibility in this population.

More Diabetes News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.